Could a common pill slow Parkinson's before symptoms appear?
NCT ID NCT04386317
Summary
This study is testing whether a medication called terazosin, already approved for blood pressure and prostate issues, can slow the progression of Parkinson's disease in people at high risk. Researchers are enrolling 15 participants who have a sleep disorder linked to Parkinson's and abnormal heart nerve scans. They will take the drug for 26 weeks to see if it improves their heart scan results, which might indicate the treatment is protecting nerves.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REM SLEEP BEHAVIOR DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Michele L Lima Gregorio
Los Angeles, California, 90046, United States
Conditions
Explore the condition pages connected to this study.